Skip to main content

Table 4 The docking results of top-ranked 5 compounds towards RORA

From: Gegen Qinlian Decoction treatment of asymptomatic hyperuricemia by targeting circadian immune function

Compound

Docking score

(kcal/mol)

H-Bond interactions

Hydrophobic interactions

Stigmasterol

− 11.6

GLN289

TRP320, CYS323, ILE327, VAL364, PHE365, MET368, VAL379, PHE391, LEU394, CYS396, PHE399, VAL403, HIS484, LYS487

beta-sitosterol

− 11.2

GLN289

TRP320, CYS323, ILE327, ALA330, VAL364, PHE365, MET368, VAL379, PHE391, LEU394, CYS396, PHE399, VAL403, HIS484, LYS487

sitosterol

− 11.2

GLN289

TRP320, CYS323, ILE327, ALA330, VAL364, PHE365, MET368, VAL379, PHE391, LEU394, CYS396, PHE399, VAL403, HIS484, LYS487

Euchrenone

− 10.6

ASP382

CYS323, ILE327, ALA330, VAL364, PHE365, ARG367, ALA371, PHE399, ILE400, VAL403

Kanzonol B

− 9.5

GLN289, LYS326

LYS326, ILE327, PHE365, PHE391, PHE399, ILE400, VAL403